PillRx only · Injection, Powder, Lyophilized, For Solution · Intravenous
Azithromycin Monohydrate
Azithromycin Monohydrate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.527
Latest avg · May 28, 2025
+0%
Since Apr 23, 2025
4
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.0K
Rx · 2026 Q1
4.4K
Units dispensed
-55%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 2 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 1 | SUPPLYING |
| Gland Pharma Limited | unknown | 1 | SUPPLYING |
| Athenex Pharmaceutical Division, LLC. | unknown | 2 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.